Related Experiment Video
Updated: Jul 9, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancer
Ruisha Tu1, Dunjing Zhong2, Ping Li3
1Department of Gastrointestinal Surgery, Hainan Cancer Hospital, Haikou, Hainan, China.
Purpose:
Individual genetic background can play an essential role in determining the development of esophageal squamous cell carcinoma (ESCC). PTPN13 and CHEK2 play important roles in the pathogenesis of ESCC. This case-control study aimed to analyze the association between gene polymorphisms and ESCC susceptibility.
Methods:
DNA was extracted from the peripheral blood of patients. The Agena MassARRAY platform was used for the genotyping. Statistical analysis was conducted using the chi-squared test or Fisher's exact test, logistic regression analysis, and stratification analysis.
Results:
The 'G' allele of rs989902 (PTPN13) and the 'T' allele of rs738722 (CHEK2) were both associated with an increased risk of ESCC (rs989902: OR = 1.23, 95% CI = 1.02-1.47, p = 0.028; rs738722: OR = 1.28, 95% CI = 1.06-1.55, p = 0.011). Stratification analysis showed that SNPs (rs989902 and rs738722) were notably correlated with an increased risk of ESCC after stratification for age, sex, smoking, and drinking status. In addition, rs738722 might be associated with lower stage, while rs989902 had a lower risk of metastasis.
Conclusion:
Our findings display that PTPN13 rs989902 and CHEK2 rs738722 are associated with an increased risk of ESCC in the Chinese Han population.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

